Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Ovarian Neoplasms

Free Subscription 29.08.2022 1 Am J Obstet Gynecol 1 Clin Cancer Res 1 Discov Oncol 1 Int J Oncol 1 J Clin Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Obstet Gynecol

1. BODURTHA SMITH AJ, Alvarez R, Heintz J, Haggerty A, et al
   Disparities in Biomarker Testing in Ovarian Cancer: A Real-World Analysis.
   Am J Obstet Gynecol. 2022 Aug 22. pii: S0002-9378(22)00686.
   PubMed        
   
   

   
   Clin Cancer Res

2. WIMBERGER P, Gerber MJ, Pfisterer J, Erdmann K, et al
   Bevacizumab may differentially improve prognosis of advanced ovarian cancer patients with low expression of VEGF-A165b, an anti-angiogenic VEGF-A splice variant.
   Clin Cancer Res. 2022 Aug 24. pii: 708584. doi: 10.1158/1078-0432.CCR-22-1326.
   PubMed         Abstract available
   
   

   
   Discov Oncol

3. SHEN J, Tao Y, He L, Guan H, et al
   Clinical application of radiotherapy in patients with oligometastatic ovarian cancer: a sharp tool to prolong the interval of systemic treatment.
   Discov Oncol. 2022;13:82.
   PubMed         Abstract available
   
   

   
   Int J Oncol

4. LI R, Wang Y, Xu Y, He X, et al
   [Retracted] Silencing the long noncoding RNA, TINCR, a molecular sponge of miR335, inhibits the malignant phenotype of epithelial ovarian cancer via FGF2 suppression.
   Int J Oncol. 2022;61.
   PubMed         Abstract available
   
   

   
   J Clin Oncol

5. SPILSBURY K, Tuesley KM, Pearson SA, Coory MD, et al
   Perioperative Beta-Blocker Supply and Survival in Women With Epithelial Ovarian Cancer and a History of Cardiovascular Conditions.
   J Clin Oncol. 2022 Aug 24:JCO2200097. doi: 10.1200/JCO.22.00097.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: